Clínic Barcelona

A novel antiviral combination has proven to be effective against hepatitis C virus in patients with HIV

Around 150 million people worldwide are infected with the hepatitis C virus (HCV) and about 5 million are also co-infected by the HIV virus. A study published in the prestigious journal The Lancet demonstrated efficacy in the treatment of HCV in HIV-infected patients with the single or combined use of two drugs administered for 12 weeks. Dr. Josep Mallolas, consultant of the Infectious Diseases Department at Hospital Clínic and researcher at the Infectious Diseases and AIDS group at IDIBAPS, has participated in the study. Hospital Clinic has been the only Spanish center that has participated in this clinical trial.